Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
ASND holding history
Ascendis Pharma A/S in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −664,307−100.0% | Sold out | Holders |
| Q2 2024 | 664,307 | $90.6M | 3.5% | +156,355+30.8% | Added | Holders |
| Q1 2024 | 507,952 | $76.8M | 2.7% | +156,252+44.4% | Added | Holders |
| Q4 2023 | 351,700 | $44.3M | 2.1% | +351,700 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −350,866−100.0% | Sold out | Holders |
| Q1 2023 | 350,866 | $37.6M | 3.6% | −1,942−0.6% | Reduced | Holders |
| Q4 2022 | 352,808 | $43.1M | 5.1% | −144,539−29.1% | Reduced | Holders |
| Q3 2022 | 497,347 | $51.4M | 7.2% | +65,177+15.1% | Added | Holders |
| Q2 2022 | 432,170 | $40.2M | 8.0% | +110,549+34.4% | Added | Holders |
| Q1 2022 | 321,621 | $37.7M | 10.0% | +103,463+47.4% | Added | Holders |
| Q4 2021 | 218,158 | $29.3M | 8.4% | – | No prior filing | Holders |